Cardio Metabolic Center Article Disclosures

Dr. Kosiborod discloses receiving research grants from AstraZeneca and Boehringer Ingelheim, and serves as a consultant for Amarin, Applied Therapeutics, AstraZeneca, Amgen, Bayer, Boehringer-Ingelheim, Eisai, Glytec, GSK, Intarcia, Janssen, Merck (Diabetes), Novartis, Novo Nordisk, and Sanofi.

Melissa Magwire RN,MSN,CDE discloses serving as a consultant for Novo Nordisk, Janssen Pharmaceuticals and Boehringer-Ingelheim.

What do you think?

Do you recommend this article?
20 readers recommendRecommended

Share this article:

Subscribe to our weekly newsletter & get more articles like this one

Recently Published News Articles

High-Intensity Interval Training for Diabetes

April 22, 2024

21 readers recommended

You notice there’s a buzz around...

Charcot Foot: Symptoms, Causes, and Treatment

April 22, 2024

22 readers recommended

Charcot foot is an uncommon, but...

Type 1 on a GLP-1 Drug? Watch for Hypoglycemia and DKA

April 22, 2024

19 readers recommended

Explore GLP-1 agonists for weight loss in type 1 diabetes with caution. Understand potential risks like hypoglycemia and DKA, while balancing benefits for heart and...

Mounjaro, Zepbound, and other incretin drugs are experiencing shortages due to high demand

Shortages for Mounjaro, Zepbound, and Others to Last Through Summer

April 22, 2024

39 readers recommended

Due to increased demand, diabetes and weight loss medications like Mounjaro, Ozempic, Wegovy, and Zepbound continue to be in short supply for the foreseeable future....

People participate in a clinical trial on diabetes education

Join Virtual Trial Investigating the Benefits of Diabetes Education

April 22, 2024

19 readers recommended

Explore the AH-HA! Project, a clinical trial enhancing type 2 diabetes education through innovative group sessions on Zoom to improve diabetes management and quality...